{"id": "1369294710758645770", "creation": 1615300273.0, "user_id": "2656754371", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 0, "reply_count": 0, "like_count": 0, "quote_count": 0}}, "text": "Merck has better luck with 2nd COVID-19 drug attempt as it sees a positive in early molnupiravir data | @Merck #RidgebackBiotherapeutics #OncoImmune #partnerships #coronavirus #Covid19 #Vaccine #Reserch #Development #molnupiravir #Biotech #NewJersey https://t.co/kQOK3COr4Y", "first_save": 1634559108.199414, "hashtags": ["#RIDGEBACKBIOTHERAPEUTICS", "#ONCOIMMUNE", "#PARTNERSHIPS", "#CORONAVIRUS", "#COVID19", "#VACCINE", "#RESERCH", "#DEVELOPMENT", "#MOLNUPIRAVIR", "#BIOTECH", "#NEWJERSEY"]}